等待开盘 04-01 09:30:00 美东时间
+0.070
+0.03%
Allstate updates financial calendar with first-quarter earnings release, conference call schedule Allstate schedules Q1 2026 earnings call for April 30, 2026, 9 a.m. ET; webcast at www.allstateinvestors.com . Q1 2026 earnings release set for April 29, 2026, after 4:15 p.m. ET; Form 8-K to be filed o
03-30 21:46
NORTHBROOK, Ill., March 30, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) announced the schedule for its first-quarter 2026 financial results and earnings conference call. Allsta...
03-30 21:46
今日重点评级关注:瑞穗:维持RELMADA THERAPEUTICS"跑赢大市"评级,目标价从10美元升至19美元;奥本海默:维持Pelthos Therapeutics"跑赢大市"评级,目标价从60美元升至62美元
03-23 13:53
Mizuho analyst Yaron Kinar maintains Allstate (NYSE:ALL) with a Outperform and lowers the price target from $281 to $265.
03-20 21:53
NORTHBROOK, Ill., March 19, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE: ALL) today announced estimated catastrophe losses for the month of February of $140 million or $111 million, ...
03-19 20:16
Allstate reports February catastrophe losses of USD 140 million Allstate reported estimated February catastrophe losses of USD 140 million, or USD 111 million after-tax. January and February total catastrophe losses were USD 315 million, or USD 249 million after-tax. Auto policies in force were 25,6
03-19 19:51
Allstate Publishes Investor Presentation on Property-Liability Growth Strategy Allstate outlined its strategy to increase personal property-liability market share by improving auto and homeowners insurance affordability, expanding distribution, and introducing new products. The company highlighted f
03-02 20:45
Key takeaways: Allstate reports identity theft cases increased 50% over the past two tax seasons, with adults in their 20s reporting more cases than other generations. Allstate Identity Prot...
02-24 21:03
今日重点评级关注:HC Wainwright & Co.:维持Ardelyx"买入"评级,目标价从10美元升至18美元;Truist Securities:维持Praxis Precision Medicine"买入"评级,目标价从500美元升至700美元
02-23 08:56
Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:ALL) with a Equal-Weight and lowers the price target from $228 to $227.
02-21 01:51